# The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease

> **NCT00006187** · PHASE3 · TERMINATED · sponsor: **Merck Sharp & Dohme LLC**

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Investigational drug

## Key facts

- **NCT ID:** NCT00006187
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** —
- **Primary completion:** 2005-06
- **Final completion:** 2005-06
- **Target enrollment:** — (—)
- **Last updated:** 2009-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006187, "The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00006187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*